Searchable abstracts of presentations at key conferences in endocrinology

ea0081p5 | Adrenal and Cardiovascular Endocrinology | ECE2022

Group education programme for patients with adrenal insufficiency: evaluation based on patients experiences

Davidse Kirsten , Geilvoet Wanda , Brinkman Lotte , van Eck J.P. , Feelders Richard , Van der Lely Aart Jan

Introduction: Adequate hormone replacement therapy in adrenal insufficiency is essential. Patients should have basic knowledge about their condition and what to do in situations which could trigger an adrenal crisis. Education on how and when hydrocortisone replacement therapy should be adjusted as well as instruction and practice an emergency injection are considered important measures to prevent an adrenal crisis. A standardized nurse-led group-based education programme (GEP...

ea0084ps3-14-128 | Thyroid Cancer CLINICAL 2 | ETA2022

Progrp as an additional screening marker in the diagnostic work up for medullary thyroid carcinoma

Schonebaum Leonoor , van Balkum Mathe , Visser W. Edward , van den Berg Sjoerd , Peeters Robin

Background: Medullary thyroid carcinoma (MTC) is a rare disease accounting for 1-3% of all thyroid carcinomas. Unfortunately, most patients present with metastasized disease: 70% with cervical lymph node metastasis and 5-10% with distant metastasis. Survival strongly correlates with stage of disease at diagnosis, illustrating the need for early diagnosis. Calcitonin is a well-established tumour marker for MTC, but its use in the screening phase is limited by a high rate of fal...

ea0090rc7.6 | Rapid Communications 7: Pituitary and Neuroendocrinology 2 | ECE2023

Acquired Hypothalamic dysfunction in childhood: “What do patients need? ”

van Roessel Ichelle , de Graaf Johan , Biermasz Nienke , Charmandari Evangelia , van Santen Hanneke

Introduction: Hypothalamic dysfunction (HD) during childhood can occur due to (treatment of) a suprasellar brain tumor. HD may not only result in pituitary dysfunction, but also in severe hyperphagia, decreased energy expenditure, diabetes insipidus with adipsia, disturbance of circadian rhythm, temperature dysregulation and behavioral problems. Currently there is no effective treatment for HD while HD has major impact on quality of life. To provide optimal care and to design ...

ea0064032 | Peptide receptor radionuclide therapy controls inappropriate calcitriol secretion in a pancreatic neuro-endocrine tumor | BES2019

Peptide receptor radionuclide therapy controls inappropriate calcitriol secretion in a pancreatic neuro-endocrine tumor

Haemels M , Delaunoit T , Van Laere K , Van Cutsem E , Verslype C , Bex M , Deroose CM

A 57 years-old patient presented with back pain, general discomfort, polydipsia, polyuria, fatigue and recent weight loss of 10 kg. Biochemical evaluation showed hypercalcemia (2.85 mmol/l; normal: 2.15–2.55) with low PTH level (14,2 ng/L; normal 14.9–56.9 ng/l) excluding primary hyperparathyroidism. The most frequent cause of hypercalcemia with non-elevated PTH levels is an underlying malignancy1. CT-thorax-abdomen showed a pancreatic neuroendocrine tumor...

ea0064036 | Medullary thyroid carcinoma in two patients with neurofibromatosis type 1 | BES2019

Medullary thyroid carcinoma in two patients with neurofibromatosis type 1

Emily Pollet , Broes Martens , Helena Van Haecke , Tatjana Sajevets , Annick Van den Bruel

Introduction: Neurofibromatosis type 1 (NF1) is an autosomal dominant neurocutaneous disorder characterised by the appearance of multiple, mostly benign, tumours throughout the skin and central nervous system. Furthermore, NF1 is associated with a number of (pre)malignant tumours including pheochromocytoma, glioma, invasive breast cancer and (pre)malignant peripheral nerve sheath tumours (1). Approximately 1:2500 to 1:3500 individuals are affected.Medull...

ea0063gp97 | Adrenal and Neuroendocrine - Basic | ECE2019

Structural changes in the zona glomerulosa of normal aging adrenals

van Bonzel Lieke , van de Wiel Elle , Deinum Jaap , Kusters Benno , Langenhuijsen Johan

Background and study aims: Increased aldosterone production in the adrenal gland plays a role in many hypertensive patients. Structural changes of the zona glomerulosa with age in normotensive patients have been described in literature but the influence of aging on aldosterone secretion and physiology is unclear. The aim of this study is to investigate changes in the ZG in order to gain insight in the origin, development and definition of aldosterone producing cell clusters (A...

ea0063p595 | Diabetes, Obesity and Metabolism 2 | ECE2019

Insulin resistance, systemic and regional inflammation in subcutaneous adipose tissue during weight loss in a population with obesity

Velde Frederique Van de , Ouwens Margriet , Batens Arsene-Helene , Shadid Samyah , Lapauw Bruno , Nieuwenhove Yves Van

Background: Adipose tissue dysfunction, such as adipocyte hypertrophy and secretion of pro-inflammatory cytokines, develops in obese subjects and goes hand in hand with obesity-related complications, especially insulin resistance (IR) and systemic inflammation. The exact mechanisms underlying adipose tissue dysfunction and consequently the obesity-related complications are not yet fully understood.Aim: Investigate the association between systemic IR and ...

ea0049ep402 | Developmental endocrinology | ECE2017

Satiety, hunger and gastrointestinal hormones after a test meal in patients after gastric bypass surgery: an association with amino acids

van den Broek Merel , de Heide Loek , Veeger Nic , Emous Marloes , van Beek Andre

Background: Nutrition is essential in achieving maximal treatment success after bariatric surgery, and is simultaneously beneficial for avoiding long-term complications. Dietary protein could have an important role, because of its positive effects on preservation of muscle mass and induction of satiety in non-bariatric subjects. Therefore, we investigated the effects of dietary protein, assessed by amino acid composition, on satiety, hunger and gastrointestinal hormones after ...

ea0049ep1045 | Pituitary - Clinical | ECE2017

Nivolumab and pembrolizumab induced hypophysitis

Vosjan-Noeverman Marleen , Brom Rob van den , Hospers Geke , Hiltermann Jeroen , Berg Gerrit van den

Introduction: Immune checkpoint blockade in cancer treatment causes frequent adverse events of auto-immune etiology. Ipilimumab (anti-CTLA-4 antibody) causes a hypophysitis in up to 10% of patients. In contrast, during treatment with nivolumab and pembrolizumab (both anti-PD-1 antibodies), hypophysitis is rare (<1%).Results: In the past year, we identified 4 cases of hypophysitis in patients treated with anti-PD-1 therapy (incidence 1% out of a total...

ea0070aep548 | General Endocrinology | ECE2020

Patient perception and views on quality of care for rare endocrine diseases. Results from an EndoERN survey

Webb Susan , Kristensen Jette , Vitali Diana , van Klink Sandra , van Beuzekom Charlotte , Nordenström Anna

Introduction: An aim of the ERNs is empowering patients, by education & learning about their experiences after diagnosis of a rare endocrine disease (RED), to identify gaps and improve outcome. Thus, EndoERN Work Package 4 designed a survey, to learn about patients perceptions on quality of care and existing gaps in diagnosis/management.Aim: Evaluate results of a 21 question survey answered on-line on a Likert scale by individual patients with RED or...